IMF Chief Medical Officer Joseph Mikhael, MD, discusses CAR T-cell therapy (chimeric antigen receptor), an approach for targeting BCMA as part of multiple myeloma treatment.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: [ Ссылка ]
Twitter: @IMFMyeloma ([ Ссылка ])
Instagram: @imfmyeloma ([ Ссылка ])
LinkedIn: [ Ссылка ])
Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
